220 related articles for article (PubMed ID: 31270707)
1. GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
Tétreault MP; Kahrilas P
Curr Rheumatol Rep; 2019 Jul; 21(8):42. PubMed ID: 31270707
[TBL] [Abstract][Full Text] [Related]
2. Advances in the evaluation and management of esophageal disease of systemic sclerosis.
Carlson DA; Hinchcliff M; Pandolfino JE
Curr Rheumatol Rep; 2015 Jan; 17(1):475. PubMed ID: 25475597
[TBL] [Abstract][Full Text] [Related]
3. Esophageal symptoms and their lack of association with high-resolution manometry in systemic sclerosis patients.
Arana-Guajardo AC; Barrera-Torres G; Villarreal-Alarcón MÁ; Vega-Morales D; Esquivel-Valerio JA
Reumatol Clin (Engl Ed); 2019; 15(3):165-169. PubMed ID: 29258795
[TBL] [Abstract][Full Text] [Related]
4. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
[TBL] [Abstract][Full Text] [Related]
5. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.
Zentilin P; Savarino V; Marabotto E; Murdaca G; Sulli A; Pizzorni C; Puppo F; Savarino E
Semin Arthritis Rheum; 2018 Feb; 47(4):569-574. PubMed ID: 28870413
[TBL] [Abstract][Full Text] [Related]
6. Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry.
Luciano L; Granel B; Bernit E; Harle JR; Baumstarck K; Grimaud JC; Bouvier M; Vitton V
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):63-69. PubMed ID: 27243115
[TBL] [Abstract][Full Text] [Related]
7. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
8. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.
Raja J; Ng CT; Sujau I; Chin KF; Sockalingam S
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):115-121. PubMed ID: 26843456
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal involvement in systemic sclerosis].
Marie I
Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
[TBL] [Abstract][Full Text] [Related]
11. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
12. Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients?
Lock G; Zeuner M; Straub RH; Hein R; Lang B; Schölmerich J; Holstege A
Rheumatol Int; 1997; 17(2):61-6. PubMed ID: 9266622
[TBL] [Abstract][Full Text] [Related]
13. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.
Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE
Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173
[TBL] [Abstract][Full Text] [Related]
14. Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life.
Crowell MD; Umar SB; Griffing WL; DiBaise JK; Lacy BE; Vela MF
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):207-213.e1. PubMed ID: 27613260
[TBL] [Abstract][Full Text] [Related]
15. Increased inspiratory esophagogastric junction pressure in systemic sclerosis: an add-on to antireflux barrier.
Nobre e Souza MÂ; Bezerra PC; Nobre RA; da Fonseca Holanda ES; dos Santos AA
World J Gastroenterol; 2015 Feb; 21(7):2067-72. PubMed ID: 25717239
[TBL] [Abstract][Full Text] [Related]
16. The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.
Horsley-Silva JL; Umar SB; Vela MF; Griffing WL; Parish JM; DiBaise JK; Crowell MD
Dis Esophagus; 2019 May; 32(5):. PubMed ID: 30715227
[TBL] [Abstract][Full Text] [Related]
17. Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.
Miele CH; Schwab K; Saggar R; Duffy E; Elashoff D; Tseng CH; Weigt S; Charan D; Abtin F; Johannes J; Derhovanessian A; Conklin J; Ghassemi K; Khanna D; Siddiqui O; Ardehali A; Hunter C; Kwon M; Biniwale R; Lo M; Volkmann E; Torres Barba D; Belperio JA; Sayah D; Mahrer T; Furst DE; Kafaja S; Clements P; Shino M; Gregson A; Kubak B; Lynch JP; Ross D; Saggar R
Ann Am Thorac Soc; 2016 Jun; 13(6):793-802. PubMed ID: 27078625
[TBL] [Abstract][Full Text] [Related]
18. Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.
Stentoft P; Hendel L; Aggestrup S
Scand J Gastroenterol; 1987 May; 22(4):499-504. PubMed ID: 3602931
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of esophageal dysfunction in progressive systemic scleroderma].
Adamek RJ; Wegener M; Cooreman MP
Dtsch Med Wochenschr; 1993 Sep; 118(37):1327-30. PubMed ID: 8375308
[No Abstract] [Full Text] [Related]
20. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
